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Abstract
Background: Cholesterol-rich membrane microdomains known as lipid rafts have been implicated in diverse
physiologic processes including lipid transport and signal transduction. Lipid rafts were originally defined as
detergent-resistant membranes (DRMs) due to their relative insolubility in cold non-ionic detergents. Recent
findings suggest that, although DRMs are not equivalent to lipid rafts, the presence of a given protein within DRMs
strongly suggests its potential for raft association in vivo. Therefore, isolation of DRMs represents a useful starting
point for biochemical analysis of lipid rafts. The physicochemical properties of DRMs present unique challenges
to analysis of their protein composition. Existing methods of isolating DRM-enriched fractions involve flotation of
cell extracts in a sucrose density gradient, which, although successful, can be labor intensive, time consuming and
results in dilute sucrose-containing fractions with limited utility for direct proteomic analysis. In addition, several
studies describing the proteomic characterization of DRMs using this and other approaches have reported the
presence of nuclear proteins in such fractions. It is unclear whether these results reflect trafficking of nuclear
proteins to DRMs or whether they arise from nuclear contamination during isolation. To address these issues,
we have modified a published differential detergent extraction method to enable rapid DRM isolation that
minimizes nuclear contamination and yields fractions compatible with mass spectrometry.
Results: DRM-enriched fractions isolated using the conventional or modified extraction methods displayed
comparable profiles of known DRM-associated proteins, including flotillins, GPI-anchored proteins and
heterotrimeric G-protein subunits. Thus, the modified procedure yielded fractions consistent with those isolated
by existing methods. However, we observed a marked reduction in the percentage of nuclear proteins identified
in DRM fractions isolated with the modified method (15%) compared to DRMs isolated by conventional means
(36%). Furthermore, of the 21 nuclear proteins identified exclusively in modified DRM fractions, 16 have been
reported to exist in other subcellular sites, with evidence to suggest shuttling of these species between the
nucleus and other organelles.
Conclusion: We describe a modified DRM isolation procedure that generates DRMs that are largely free of
nuclear contamination and that is compatible with downstream proteomic analyses with minimal additional
processing. Our findings also imply that identification of nuclear proteins in DRMs is likely to reflect legitimate
movement of proteins between compartments, and is not a result of contamination during extraction.
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Background
Lipid rafts and caveolae, membrane microdomains that
are enriched in cholesterol and sphingolipids, have been
implicated in diverse physiologic mechanisms, such as
signal transduction, trafficking and lipid transport [1,2].
The invaginated and vesicular structures known as caveo-
lae are a type of microdomain that harbor caveolin family
proteins; however, non-caveolar 'flat' lipid rafts have also
been shown to exist in cells that do not express caveolins
[3]. Lipid rafts were originally defined as detergent-resist-
ant membranes (DRMs) because of their relative insolu-
bility in cold non-ionic detergents [4]. However, equating
DRMs with lipid rafts is now believed to be inaccurate due
to controversy over the biophysical and biochemical
nature of rafts, and whether they even exist in vivo [3,5-7].
In addressing these concerns, several recent papers have
proposed a revision of the raft hypothesis. These studies
suggest that, although DRMs do not correspond to lipid
rafts as they exist in vivo, the presence of a given protein
within a DRM, and its loss from that fraction when DRMs
are perturbed by cholesterol depletion, for example,
strongly suggests the potential for raft association of that
protein in vivo [8-10]. In addition, it has been noted in a
recent publication that, despite its limitations, isolation of
DRMs is the only biochemical approach for assessing pro-
tein interactions with rafts [10].
DRMs are thought to be diverse in protein content and in
functional roles. However, these membrane domains are
still poorly understood and are currently being character-
ized using proteomics tools [11]. The cell signaling func-
tion of DRMs is thought to arise from the ability of these
microdomains to selectively retain or exclude specific pro-
teins, resulting in the formation of multiprotein com-
plexes that process biochemical information across
specific signaling axes. Because cholesterol-rich microdo-
mains may be functionally altered by pathophysiologic
alterations in lipid metabolism [12], systematic analysis
of proteins present in DRMs is likely to provide novel
insights into multiple signaling mechanisms that operate
in the normal state and in disease.
The biophysical and biochemical properties of DRMs
present unique challenges to studies of their protein com-
position. Membrane proteins possess hydrophobic
regions that render them poorly soluble during extraction
[13,14]. In addition, DRMs represent a minor and tran-
sient component of the total membrane surface. The clas-
sical method of isolating DRM-enriched fractions is by
flotation of cell extracts, prepared in cold detergents such
as Triton X-100 or under detergent-free conditions, in a
sucrose density gradient [15]. This approach exploits the
detergent insolubility of DRMs at low temperatures as
well as their light buoyant density. However, gradient cen-
trifugation procedures are time-consuming and labor-
intensive, requiring processing times on the order of 24 h.
Moreover, the resultant dilute, sucrose-containing frac-
tions have limited utility for proteomic analysis without
additional processing steps [16].
We have employed a DRM isolation technique originally
described by Solomon et al. [17,18] that exploits the dif-
ferential solubility of detergent-resistant microdomains in
cold, non-ionic detergents [19-24]. This approach is rapid
and yields fractions that are comparable to those isolated
by flotation on density gradients. We have validated our
observations from the detergent extraction procedure
using alternative approaches, including sucrose density
ultracentrifugation and immunofluorescence imaging
[21,23,24]. Both unpublished and published data from us
and others revealed the presence of nuclear proteins in
DRM fractions isolated either by flotation in density gra-
dients or by differential detergent solubility [16,25-
30](N.K.M. and R.M.A, unpublished observations). How-
ever, whether this unanticipated finding arose from intra-
cellular trafficking of proteins between nuclei and DRMs,
or, alternatively, was a reflection of nuclear contamina-
tion during extraction has not been determined. In this
study, we describe a modification of the existing differen-
tial detergent extraction procedure that minimizes nuclear
contamination of DRMs. Proteomic analysis of the result-
ing fractions suggests that the presence of 'nuclear' pro-
teins in DRMs is likely to result from shuttling between
the nucleus and other subcellular sites.
Results and discussion
To investigate whether the presence of nuclear proteins in
DRMs was an artifact or instead reflected physiologic traf-
ficking events, we modified the extraction procedure
described by Solomon et al. by pelleting out nuclei and
intact cells from detergent-free homogenates prior to
detergent solubilization. We reasoned that this would
reduce potential contamination from nuclear material. As
a model system, we have used caveolin-negative LNCaP
prostate cancer cells stably expressing myristoylated Akt1
(MyrAkt1)[24]. MyrAkt1 is a robust marker of DRMs in
these cells based on (i) its presence in light buoyant den-
sity fractions following sucrose gradient centrifugation;
(ii) its enrichment in DRMs following differential deter-
gent extraction; and (iii) its accumulation at the plasma
membrane based on localization to membranes that stain
with CTxB, a marker of the DRM/lipid raft-restricted gan-
glioside GM1 (Figure 1A)[31].
To determine the effect of pelleting nuclei and/or intact
cells on the overall protein profiles of isolated fractions,
we initially compared the conventional extraction
method with the modified procedure. As starting material
for the extraction, we generated membrane preparations
from LNCaP/MyrHA-Akt1 or LNCaP/LacZ cells in log-BMC Cell Biology 2008, 9:30 http://www.biomedcentral.com/1471-2121/9/30
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Modification of the detergent extraction procedure eliminates 'nuclear' proteins from detergent-resistant membranes Figure 1
Modification of the detergent extraction procedure eliminates 'nuclear' proteins from detergent-resistant 
membranes. (A) Cholesterol- and sphingolipid-enriched membranes in LNCaP/MyrAkt1 cells were stained with 0.5 μg/mL 
Alexa 594-CTxB for 10 min prior to staining with anti-S473-P Akt (1:100) and FITC-conjugated secondary Ab (1:100). Nuclei 
were counterstained with DAPI prior to imaging. Original magnification, 63×. LNCaP cells stably expressing LacZ or MyrAkt1 
were extracted using the conventional (1) or modified (2) detergent extraction procedure. Equal amounts (30 μg for detection 
of SAFB; 10 μg for other target proteins) of Triton-soluble (TS), Triton-insoluble, octylglucoside-soluble (TI) or nuclear (N) 
fractions were resolved by SDS-PAGE, transferred to nitrocellulose membranes and (B) stained with Ponceau S or (C) blot-
ted with antibodies to the HA epitope tag, phospho-S473 Akt, PCNA, SAFB, hnRNP K and Giα2.
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phase growth by mechanical disruption of cells under
detergent-free conditions, as described in Methods. In the
conventional method, homogenized samples were centri-
fuged at 16,000 × g in a Beckman microcentrifuge for 10
min at 4°C. In the modified approach, samples were cen-
trifuged at 500 × g for 5 min at 4°C to pellet intact cells
and nuclei; importantly, no brake was applied during the
deceleration of the centrifuge. The supernatant was
decanted carefully and centrifuged at 16,000 × g in a Beck-
man microcentrifuge for 10 min at 4°C to pellet mem-
branes. The pellet remaining from the low-speed spin,
comprising predominantly nuclei, was lysed in 50 mM
Tris-HCl pH 8.0, 150 mM NaCl, 1% Igepal CA-630, 0.5%
sodium deoxycholate and 0.1% SDS plus protease and
phosphatase inhibitors. In each case (conventional or
modified), pellets from the high-speed centrifugation
steps were then subjected to successive detergent extrac-
tion in Triton X-100 and octylglucoside to yield Triton-
soluble (TS) and Triton-insoluble/octylglucoside-soluble
(TI) fractions, as described in Methods.
Following determination of the protein concentration of
fractions by MicroBCA assay, equal amounts of protein
from each fraction were resolved by SDS-PAGE and trans-
ferred to nitrocellulose membranes. To verify the presence
of protein in each fraction, membranes were stained with
0.1% (w/v) Ponceau S in 5% acetic acid (v/v) prior to
blotting with the indicated antibodies. The staining pat-
tern revealed both quantitative and qualitative differences
in the overall protein profiles of TS and TI fractions gener-
ated by the two methods (Figure 1B). We confirmed the
distribution of MyrAkt1 in TS, TI and nuclear (N) fractions
by HA immunoblot, and observed robust enrichment of
MyrAkt1 in TI fractions in both cases (Figure 1C). A small
amount of MyrAkt1 was detected in the nuclear pellet
from the low speed centrifugation, consistent with previ-
ous reports [32]. To determine the impact of the modified
extraction procedure on protein distribution, we probed
the membranes for selected proteins with defined subcel-
lular localizations, including proliferating cell nuclear
antigen (PCNA), a nuclear protein [33] and the small G-
protein, Giα2, that resides in lipid rafts [34,35]. As shown
in Figure 1C, PCNA, although present in the TI fraction
following the conventional extraction method, was unde-
tectable in TI fractions prepared with the modified
approach. As anticipated, the nuclear fraction showed
robust signal corresponding to PCNA. In contrast, Giα2
was present in TI fractions generated with either extraction
method, consistent with its localization to DRMs. These
data were reproducible across three independent biologi-
cal replicates and similar findings were obtained with frac-
tions isolated from LNCaP cells stably expressing the
irrelevant gene (LacZ). We also probed for two additional
proteins that were identified as putative raft-resident
binding partners of MyrAkt1 transiently expressed in
HEK293 cells (N.K.M. and R.M.A, unpublished observa-
tions): scaffold attachment factor B (SAFB), a protein
implicated in transcriptional regulation and chromatin
organization [36]; and heterogeneous ribonucleoprotein
K (hnRNP K), a pleiotropic nucleic acid binding protein
that regulates gene and protein expression [37,38].
Although SAFB was present in TI fractions generated by
conventional means, it was absent from this material fol-
lowing elimination of nuclei, strongly suggesting that its
presence in the TI fraction arose from nuclear contamina-
tion. In contrast, hnRNP K was detected in TS and TI frac-
tions with both extraction methods, as well as in nuclei.
These observations are consistent with localization of
hnRNP K to multiple distinct subcellular sites [37].
To extend our analysis beyond characterization of specific
proteins and to determine the potential utility of our
modified fractionation procedure for proteomic applica-
tions, we used LC/MS as a read-out for the proteome com-
positions of TI fractions generated using either the
conventional or modified methods. The TI fractions from
the two extraction methods were subjected to in-solution
tryptic digestion and mass spectrometry analysis, as
described in Methods. According to the criteria outlined
in Methods, 388 and 371 proteins were identified from
the TI fractions isolated using the conventional and mod-
ified methods, respectively [see Additional file 1]. This
proteomic analysis was not meant to be exhaustive.
Instead we used the most confident protein identifica-
tions to a) ensure that the lipid raft isolation was success-
ful and b) estimate the fraction of nuclear proteins.
Common proteins identified in the TI fractions from both
extraction methods included a number of proteins previ-
ously reported to be associated with DRMs, lipid rafts
and/or caveolae (Table 1), such as flotillins
[16,25,29,39,40], heterotrimeric G-protein subunits [25],
components of the vacuolar ATP synthase protein family
[16,25,29,41] and others [29,42-44]. Thus, the modified
fractionation procedure did not alter the predicted com-
position of DRM fractions significantly and yielded frac-
tions consistent with those isolated by density gradient-
based methods.
To assess the impact of the modified extraction procedure
on the protein profiles obtained from each fraction, we
classified proteins according to subcellular localization. In
particular, we focused on whether proteins were nuclear
or non-nuclear in nature. Datasets were annotated using
Gene Ontology Cellular Component (GO-CC) terms with
the cross-reference converter [45]. As shown in Figure 2A,
we observed a striking difference in the number of nuclear
proteins differentially identified with the two approaches.
Specifically, the modified extraction procedure led to
identification of many fewer nuclear proteins, with only
54 out of 371 proteins (15%) classified as nuclear. ThisBMC Cell Biology 2008, 9:30 http://www.biomedcentral.com/1471-2121/9/30
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Table 1: Proteins identified by tandem mass spectrometry.
(A) Proteins associated with DRMs
DRM proteins References
Accession # Score Description
IPI00006211 175 VAMP (Vesicle-associated membrane protein)-
associated protein B and Ca
[42]
IPI00008453 122 Coronin-1C [26]
IPI00013981 95 YES tyrosine kinase [25]
IPI00015148 131 Ras-related protein Rap-1b [40]
IPI00018511 95 Tubulin beta-4q chain [40]
IPI00022418 285 Splice Isoform 1 of Fibronectin precursor [26]
IPI00027438 388 Flotillin-1 [16, 25, 39]
IPI00029625 133 Flotillin-2 [16, 29, 39, 40]
IPI00030910 185 GPI-anchored protein p137a [43]
IPI00030919 95 Mitogen-activated protein kinase kinase 1 interacting 
protein 1
[25], [40]
IPI00030939 185 Alpha subunit of GsGTP binding protein [25]
IPI00216308 2152 Voltage-dependent anion-selective channel protein 1 [44]
IPI00220416 101 Ubiquinol-cytochrome c reductase complex 14 kDa 
protein
[29, 44]
IPI00221232 106 G-protein gamma-12 subunit variant [25]
IPI00334190 552 Stomatin-like protein 2 [44]
IPI00337415 81 Guanine nucleotide-binding protein G(i) alpha-1 
subunit
[25]
IPI00339269 163 Heat shock 70 kDa protein 6 [40]
IPI00440493 440 ATP synthase alpha chain, mitochondrial precursor [40]
IPI00554701 72 Ubiquinol-cytochrome c reductase complex 7.2 kDa 
protein
[29, 44]
IPI00554711 603 Junction plakoglobin [25]
IPI00641181 143 MARCKS-like 1 [28]
(B) Nuclear proteins shown to exist in other 
subcellular locations
Nuclear proteins
Accession # Score Description Evidence for shuttling
IPI00000690 87 Splice Isoform 1 of Programmed cell death protein 8, 
mitochondrial precursor
Yes: [46]
IPI00012048 76 Nucleoside diphosphate kinase A Yes: [47]
IPI00012442 190 Ras-GTPase-activating protein binding protein 1 Yes: [48]
IPI00016249 91 Fragile X mental retardation syndrome-related protein 
1
Yes: [49]
IPI00016250 71 Fragile X mental retardation syndrome-related protein 
2
Yes: [49]
IPI00021840 230 40S ribosomal protein S6 Yes: [50]
IPI00023591 158 Transcriptional activator protein PUR-alpha No:
IPI00024157 114 FK506-binding protein 3 No: 
IPI00027096 74 39S ribosomal protein L19, mitochondrial precursor Yes: UniProt 49406
IPI00027415 171 MLEL1 protein No: 
IPI00028376 92 Mitochondrial import inner membrane translocase 
subunit TIM8 A
Yes: [51]
IPI00032003 60 Emerin No:
IPI00042578 83 Similar to heterogeneous nuclear ribonucleoprotein 
A1 isoform a
Yes: [58]
IPI00165506 125 Polymerase delta interacting protein 2 Yes: [52]
IPI00215637 131 DEAD-box protein 3, X-chromosomal Yes: [53]
IPI00215780 167 40S ribosomal protein S19 Yes: [54]
IPI00217468 87 Histone H1.5 No:
IPI00219330 206 Splice Isoform 5 of Interleukin enhancer-binding factor 
3
Yes: [55]
IPI00328715 216 LYRIC protein Yes: [56]BMC Cell Biology 2008, 9:30 http://www.biomedcentral.com/1471-2121/9/30
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was in marked contrast to the conventional method in
which 141 out of 388 proteins (36%) were categorized as
nuclear. At the same time, the number of proteins anno-
tated as non-nuclear increased from 195 (50%) to 258
(70%). The Venn diagrams in Figure 2B clearly show that
the decrease of nuclear proteins in the modified protocol
is concomitant to the increase in non-nuclear proteins.
These findings are in agreement with our findings by
immunoblot analysis that the nuclear proteins PCNA and
SAFB are no longer detectable in TI fractions generated
using the modified fractionation technique.
Interestingly, of the 21 proteins annotated as nuclear in
localization, that were found exclusively in the modified
TI fraction, evidence from the literature and protein data-
bases suggests that 16 of these are also present in addi-
tional subcellular locations, and may shuttle between the
nucleus and other sites in the cell [46-58]. Thus, only 5
proteins (shaded in Table 1B), out of a total of 156 specif-
ically identified in the modified TI fraction in this experi-
ment, were present exclusively in nuclei. In addition, at
least 60% of the 33 nuclear proteins identified with both
approaches are also present in other subcellular locations.
In contrast, only about 30% of the 108 nuclear proteins
specifically identified in the conventional TI fraction are
annotated to be present in additional locations.
These findings strongly suggest that the modified DRM
extraction method generates fractions that are largely free
of nuclear contamination. They also imply that, given the
high frequency with which so-called 'nuclear proteins' are
found in other organelles, due to shuttling between com-
partments, nuclear proteins are likely to be detected by
most extraction procedures, even when performed under
the most stringent conditions. Canonical nuclear pro-
teins, such as nuclear hormone receptors, can shuttle
between the cytoplasm and nuclear compartments as part
of their hormone-dependent functions. Recently, the
androgen receptor was found to process androgenic sig-
nals non-genomically by forming a complex with Akt1 in
lipid raft microdomains [59]. The identification of such
proteins in DRMs may thus reflect a legitimate physio-
logic process and not an experimental artifact.
Conclusion
In summary, we describe a rapid, robust method for isola-
tion of detergent-resistant membrane fractions that are
compatible with downstream proteomic analyses with
minimal additional processing. The present approach
allows for a significant reduction of nuclear protein con-
tamination of DRM samples. We believe the results pre-
sented here indicate that the DRM isolation procedure we
describe can be applied with confidence to settings where
a robust characterization of DRM constituents by mass
spectrometry is desired, and also to more traditional bio-
chemical methods involving antibody-based analyses.
Methods
Membrane preparations and isolation of detergent 
resistant membrane fractions
Populations of LNCaP/MyrHA-Akt1 or LNCaP/LacZ cells
in log-phase growth were rinsed twice with phosphate-
buffered saline (PBS), resuspended in Buffer M [50 mM
HEPES pH 7.4, 10 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA
plus protease inhibitor cocktail (Complete Mini, Roche
Applied Science), 1 mM Na3VO4, 1 mM NaF and 1 mM
Na4P2O7.10 dH2O] and homogenized at 4°C using a Pot-
ter-Elvehjem tissue grinder (12 strokes, 1800 rpm). 107-
108 cells were used for each extraction method. High-
speed (16,000 × g) pellets from either the conventional or
modified approach were subjected to successive detergent
extraction essentially as described [19,21,24]. Briefly, pel-
lets were resuspended in Buffer A [25 mM 2-(N-mor-
pholino)-ethanesulfonic acid, 150 mM NaCl, pH 6.5] and
samples combined with an equal volume of Buffer A con-
taining 2% Triton X-100, and phosphatase and protease
inhibitors. Samples were incubated on ice for 60 min, cen-
trifuged at 16,000 × g for 20 min at 4°C and supernatants
collected as Triton-soluble (TS) material. Pellets were
rinsed briefly with Buffer A and resuspended in Buffer B
[10 mM Tris-Cl, pH 7.6, 150 mM NaCl, 60 mM β-
octylglucoside and phosphatase and protease inhibitors].
Samples were incubated on ice for 30 min, centrifuged at
16,000 × g for 20 min at 4°C and supernatants collected
as Triton-insoluble (TI) material.
Tryptic Digestion and Mass Spectrometry Analysis
Four micrograms of each TI fraction was subjected to in-
solution tryptic digestion. Three MS experiments were per-
formed: TI fraction from the conventional extraction pro-
IPI00410693 94 Splice Isoform 1 of Plasminogen activator inhibitor 1 
RNA-binding protein
Yes: [57]
IPI00456731 123 Similar to Laminin receptor 1 Yes: UniProt P08865
(A) The table illustrates proteins identified in DRM fractions generated using the modified fractionation method that have previously been described 
as present in or associated with DRMs isolated by other methods. (B) The table lists proteins identified in the modified DRM (TI) fraction that are 
indicated to be nuclear-localized based on Gene Ontology Cellular Component terminology, but that have been reported to exist in other 
locations. Proteins that are restricted to nuclei are shaded in grey.
aLikely DRM-associated.
Table 1: Proteins identified by tandem mass spectrometry. (Continued)BMC Cell Biology 2008, 9:30 http://www.biomedcentral.com/1471-2121/9/30
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cedure; TI fraction from the modified extraction
procedure; and extraction buffer control with a single rep-
licate for each. Approximately 2 μL protein extracts or
extraction buffer as control, were mixed with 8 μL 0.2%
RapiGest™ SF (Waters Corporation, Milford, MA) in 50
mM ammonium bicarbonate, boiled for 5 min and
cooled to room temperature. Dithiothreitol was added to
5 mM final concentration, samples heated at 60°C for 30
min and cooled to room temperature. Iodoacetamide was
added to 15 mM final concentration and samples were
incubated protected from light for 30 min prior to addi-
tion of 100 ng MS-grade trypsin and further incubation at
37°C for 2 h. To hydrolyze the RapiGest™ surfactant, trif-
luoroacetic acid was added to a final concentration of
0.5% and samples were incubated at 37°C for 45 min.
Following centrifugation at 14,000 × g for 10 min, the
supernatants were transferred to screw-top vials. Ace-
tonitrile and acetic acid were added to a final concentra-
tion of 7.5% and 1.5%, respectively. Samples were
analyzed by online C18 nanoflow reversed-phase HPLC
(Eksigent nanoLC·2D™) hyphenated to a Thermo Scien-
tific LTQ Orbitrap mass spectrometer. The digest was
loaded onto a 100 μm i.d. × 15 cm C18 column and the
peptides were separated at 200 nL/min with 80 min gradi-
ents from 5 to 31.5% acetonitrile in 0.4% formic acid. Sur-
vey spectra were acquired in the orbitrap with the
resolution set to a value of 30,000. Up to five of the most
intense ions per cycle were fragmented and analyzed in
the linear trap.
Database searching was performed using the Mascot
search engine (Matrix Science, v.2.1). All MS datasets were
searched against the International Protein Index (IPI)
human protein database of the International Protein
Index (v3.10; 57479 sequences). Protein modifications
were selected as carbamidomethyl (C) (fixed) and oxida-
tion (M) (variable). Up to one missed cleavage was
allowed. The mass tolerance was set as ± 20 ppm for MS
spectra and ± 0.5 Da for MS/MS spectra. The following cri-
teria were used to generate a high-confidence data set: at
least two peptides must be identified for each protein,
with a score not less than 33, corresponding to a signifi-
cance level of p < 0.01 as determined by reverse database
searching. Known contaminants (e.g. keratins and
trypsin) were removed from the protein lists. Applying
these parameters, no false positives were identified
through searching the reversed IPI_Human database.
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Additional material
Additional file 1
MS Data Summary. The table summarizes MS data obtained from DRM 
fractions isolated using either the conventional or modified extraction pro-
cedures.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-30-S1.xls]
Quantitative analysis of proteins in detergent-resistant mem- brane fractions analyzed by mass spectrometry Figure 2
Quantitative analysis of proteins in detergent-resist-
ant membrane fractions analyzed by mass spectrom-
etry. (A) Proteins in DRM (TI) fractions generated using the 
conventional or modified methods were analyzed by tandem 
mass spectrometry and classified as either nuclear, non-
nuclear or unannotated based on Gene Ontology cellular 
component terms. The pie-charts demonstrate the marked 
reduction in proteins identified as 'nuclear' with the modified 
extraction procedure. (B) Venn diagrams illustrating the dis-
tinct and overlapping protein compositions of TI fractions 
isolated by each method.BMC Cell Biology 2008, 9:30 http://www.biomedcentral.com/1471-2121/9/30
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